Nogo-B expression, in arterial intima, is impeded in the early stages of atherosclerosis in humans

APMIS

Volumn 122, Issue 9, 2014, Pages 742-749

  Drozdz, Katarzyna ^a,b   Grzegorek, Irmina ^a,c   Chmielewska, Magdalena ^a,c   Gomulkiewicz, Agnieszka ^a,c   Jablońska, Karolina ^a,c   Piotrowska, Aleksandra ^a,c   Karczewski, Maciej ^a   Janczak, Dariusz ^a,b,c   Patrzalek, Dariusz ^a,c   Dziegiel, Piotr ^a,c   Szuba, Andrzej ^a,b,c  

^a Specialized Hospital in Wroclaw   (Poland)

^b 4TH MILITARY HOSPITAL   (Poland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Atherosclerosis; Intima; Macrophages; Nogo B

Indexed keywords

CD68 ANTIGEN; PROTEIN NOGO; PROTEIN NOGO B; UNCLASSIFIED DRUG; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MESSENGER RNA; MYELIN PROTEIN;

ADULT; ADVENTITIA; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL DENSITY; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MIDDLE AGED; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; STATISTICAL ANALYSIS; WESTERN BLOTTING; BIOSYNTHESIS; DONOR; GENETICS; IMMUNOLOGY; INFLAMMATION; INTIMA; METABOLISM; NEOINTIMA; PATHOLOGY;

ADVENTITIA; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ATHEROSCLEROSIS; FEMALE; HUMANS; INFLAMMATION; MACROPHAGES; MALE; MYELIN PROTEINS; NEOINTIMA; RNA, MESSENGER; TISSUE DONORS; TUNICA INTIMA;

EID: 84906791220     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12212     Document Type: Article

References (24)

1. Badimon L, Storey RF, Vilahur G. Update on lipids, inflammation and atherothrombosis. Thromb Haemost 2011;105(Suppl 1):S34-42.
2. Wilcox JN, Scott NA. Potential role of the adventitia in arteritis and atherosclerosis. Int J Cardiol 1996;54:S21-35.
3. Wilcox JN, Okamoto EI, Nakahara KI, Vinten-Johansen J. Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors? Ann N Y Acad Sci 2001;947:68-90.
4. Wallner K, Sharifi BG, Shah PK, Noguchi S, DeLeon H, Wilcox JN. Adventitial remodeling after angioplasty is associated with expression of tenascin mRNA by adventitial myofibroblasts. J Am Coll Cardiol 2001;37:655-61.
5. Xu F, Ji J, Li L, Chen R, Hu WC. Adventitial fibroblasts are activated in the early stages of atherosclerosis in the apolipoprotein E knockout mouse. Biochem Biophys Res Commun 2007;352:681-8.
6. Li G, Chen SJ, Oparil S, Chen YF, Thompson JA. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 2000;101:1362-5.
7. Gossl M, Versari D, Mannheim D, Ritman EL, Lerman LO, Lerman A. Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia - implications for vulnerable plaque-development. Atherosclerosis 2007;192:246-52.
8. Herrmann J, Lerman LO, Rodriguez-Porcel M, Holmes DR Jr, Richardson DM, Ritman EL, et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res 2001;51:762-6.
9. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, et al. Folkman Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 2003;100:4736-41.
10. Kumamoto M, Nakashima Y, Sueishi K. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol 1995;26:450-6.
11. Nakano T, Nakashima Y, Yonemitsu Y, Sumiyoshi S, Chen YX, Akishima Y, et al. Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries. Hum Pathol 2005;36:330-40.
12. Acevedo L, Yu J, Erdjument-Bromage H, Miao RQ, Kim JE, Fulton D, et al. A new role for Nogo as a regulator of vascular remodeling. Nat Med 2004;10:382-8.
13. Paszkowiak JJ, Maloney SP, Kudo FA, Muto A, Teso D, Rutland RC, et al. Evidence supporting changes in Nogo-B levels as a marker of neointimal expansion but not adaptive arterial remodeling. Vascul Pharmacol 2007;46:293-301.
14. Rodriguez-Feo JA, Hellings WE, Verhoeven BA, Moll FL, de Kleijn DP, Prendergast J, et al. Low levels of Nogo-B in human carotid atherosclerotic plaques are associated with an atheromatous phenotype, restenosis, and stenosis severity. Arterioscler Thromb Vasc Biol 2007;27:1354-60.
15. Pan JW, Wei M, Yang PY, Zheng X, Li JB, Lu ZG, et al. Regulation of Nogo-B expression in the lesion of aortic aneurysms. Clin Exp Pharmacol Physiol 2007;34:856-60.
16. GrandPre T, Nakamura F, Vartanian T, Smitrittmater SM. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000;403:439-44.
17. Dodd DA, Niederoest B, Bloechlinger S, Dupuis L, Loeffler JP, Schwab ME, et al. and -C are found on the cell surface and interact together in many different cell types. J Biol Chem 2005;280:12494-502.
18. Josephson A, Trifunovski A, Widmer HR, Widenfalk J, Olson L, Spenger C. Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans. J Comp Neurol 2002;453:292-304.
19. Oertle T, Huber C, van der Putten H, Schwab ME. Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J Mol Biol 2003;325:299-323.
20. Kim JE, Li S, GrandPre T, Qiu D, Strittmatter SM. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 2003;38:187-99.
21. Yu J, Fernández-Hernando C, Suarez Y, Schleicher M, Hao Z, Wright PL, et al. Reticulon 4B (Nogo-B) is necessary for macrophage infiltration and tissue repair. Proc Natl Acad Sci U S A 2009;106:17511-6.
22. Lee WS, Kim SW, Hong SA, Lee TJ, Park ES, Kim HJ, et al. Atherosclerotic progression attenuates the expression of Nogo-B in autopsied coronary artery: pathology and virtual histology intravascular ultrasound analysis. J Korean Med Sci 2009;24:596-604. Epub 2009 Jul 29.
23. Watanabe M, Sangawa A, Sasaki Y, Yamashita M, Tanaka-Shintani M, Shintaku M, et al. Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. J Atheroscler Thromb 2007;14:325-31.
24. Drozdz K, Janczak D, Dziegiel P, Podhorska M, Piotrowska A, Patrzalek D, et al. Adventitial lymphatics and atherosclerosis. Lymphology 2012;45:26-33.